Vladimir Bobek1, Andrzej Majewski2, Katarina Kolostova3, Adam Rzechonek4, Robert Lischke5, Jan Schutzner5, Grzegorz Kacprzak6. 1. Department of Laboratory Genetics, University Hospital Kralovske VinohradyPrague, Czech Republic; Department of Histology and Embryology, Wroclaw Medical UniversityWrocław, Poland; 3rd Department of Surgery, First Faculty of Medicine Charles University in Prague and University Hospital MotolCzech Republic. 2. Department of Thoracic Surgery, Nottingham City Hospital Nottingham, UK. 3. Department of Laboratory Genetics, University Hospital Kralovske Vinohrady Prague, Czech Republic. 4. Department of Thoracic Surgery, Wroclaw Medical UniversityWroclaw, Poland; Wroclaw Thoracic Surgery Centre, Lower Silesian Centre of Lung DiseasesWroclaw, Poland. 5. 3rd Department of Surgery, First Faculty of Medicine Charles University in Prague and University Hospital Motol Czech Republic. 6. Department of Thoracic Surgery, Wroclaw Medical University Wroclaw, Poland.
Abstract
INTRODUCTION: Pleural empyema is a severe complication of various diseases. The essential is the inserting a drain into the pleural cavity and evacuation of the pus. Sometimes the pus is very thick and its evacuation and re-expansion of the lung is very difficult. METHODS: We report a group of 10 patients with intrapleural administration of Pulmozyme (dornase alpha) in dosages of either 2.5 mg once or on two separate occasions. All of the patients had a chest tube inserted into the pleural cavity. Measurement of viscosity was done before and after the instillation of the dornase alpha. RESULTS: In six patients dornase alfa was introduced into the pleural cavity once. Three of them received this on the 4th whilst the rest were treated with the agent on the 6th day. Four patients received the dornase alpha twice because of the small amount of drainage fluid after the previous instillation. Five patients were discharged from hospital with complete re-expansion of their lungs. Two patients were qualified for a surgical operation since the lung was trapped and did not re-expand. Three patients had to be discharged with a drain as a result of incomplete re-expansion of the lung. In all the patients the density of the pus after administering the dornase alpha decreased and the amount of the pus drainage increased. CONCLUSIONS: Dornase alpha may be used in some patients with pleural empyema with good results.
INTRODUCTION:Pleural empyema is a severe complication of various diseases. The essential is the inserting a drain into the pleural cavity and evacuation of the pus. Sometimes the pus is very thick and its evacuation and re-expansion of the lung is very difficult. METHODS: We report a group of 10 patients with intrapleural administration of Pulmozyme (dornase alpha) in dosages of either 2.5 mg once or on two separate occasions. All of the patients had a chest tube inserted into the pleural cavity. Measurement of viscosity was done before and after the instillation of the dornase alpha. RESULTS: In six patients dornase alfa was introduced into the pleural cavity once. Three of them received this on the 4th whilst the rest were treated with the agent on the 6th day. Four patients received the dornase alpha twice because of the small amount of drainage fluid after the previous instillation. Five patients were discharged from hospital with complete re-expansion of their lungs. Two patients were qualified for a surgical operation since the lung was trapped and did not re-expand. Three patients had to be discharged with a drain as a result of incomplete re-expansion of the lung. In all the patients the density of the pus after administering the dornase alpha decreased and the amount of the pus drainage increased. CONCLUSIONS: Dornase alpha may be used in some patients with pleural empyema with good results.
Authors: Zhiwen Zhu; Michael L Hawthorne; Yubiao Guo; Wonder Drake; Semra Bilaceroglu; Heather L Misra; Richard W Light Journal: Chest Date: 2006-06 Impact factor: 9.410
Authors: Najib M Rahman; Nicholas A Maskell; Alex West; Richard Teoh; Anthony Arnold; Carolyn Mackinlay; Daniel Peckham; Chris W H Davies; Nabeel Ali; William Kinnear; Andrew Bentley; Brennan C Kahan; John M Wrightson; Helen E Davies; Clare E Hooper; Y C Gary Lee; Emma L Hedley; Nicky Crosthwaite; Louise Choo; Emma J Helm; Fergus V Gleeson; Andrew J Nunn; Robert J O Davies Journal: N Engl J Med Date: 2011-08-11 Impact factor: 91.245
Authors: Grzegorz Kacprzak; Andrzej Majewski; Jerzy Kolodziej; Adam Rzechonek; Robert Gürlich; Vladimir Bobek Journal: Braz J Infect Dis Date: 2013-01-16 Impact factor: 3.257